Search Results 481-490 of 10647 for Clopidogrel

  1. Lemborexant (oral route) - Mayo Clinic

    Lemborexant is used to treat insomnia (sleeping problems). It belongs to the group of medicines called central nervous system (CNS) depressants. These medicines ...

  2. COPD - Doctors and departments - Mayo Clinic

    Pulmonary scientists at Mayo Clinic conduct comprehensive basic and clinical research ― including conducting clinical trials ― to improve early diagnosis and ...

  3. Patient Stories - Todd A. Kellogg, M.D. - Mayo Clinic

    The deadline to have twice the impact to advance healthcare research is May 15. Give Today · Find a doctor · Explore careers.

  4. Bezlotoxumab (MK-6072) Versus Placebo In Children With Clostridium Difficile Infection (CDI) (MK-6072-001) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. A Study to Evaluate Bio-markers Associated with Improved Glucose Control in Patients with Type 1 Diabetes - Mayo Clinic

    About this study. The purpose of this study is to collect blood samples for biomarker assessment in type 1 diabetes prior to and at specific time points ...

  6. Study Comparing CB-839 With Cabozantinib Vs. Cabozantinib With Placebo In Patients With Metastatic Renal Cell Carcinoma - Mayo Clinic

    ... clopidogrel) is allowed in patients without brain metastases who are on stable doses for at least 4 weeks before randomization and have had no complications ...

  7. Erlotinib Hydrochloride And Cabozantinib-s-Malate Alone Or In Combination As Second Or Third Line Therapy In Treating Patients With Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

    ... clopidogrel [clopidogrel bisulfate]); (low dose aspirin [≤ 81 mg/day] and prophylactic LMWH are permitted); No concomitant treatment of strong cytochrome ...

  8. Publications - Courtney M. Hrdlicka, M.D. - Mayo Clinic

    Publications · Smith BH, Wolfe JG, Karam A, Demarkschalk BM, Hrdlicka CM, Nasr DM, Chukwudelunzu FE, Nord CA, Pahl EA, Fernandez C, Wood S, Woodhead ZV, Carone D ...

  9. A Safety And Effectiveness Study Of Defibrotide In The Prevention Of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. A Study To Evaluate The Safety Of Lixivaptan In Subjects Previously Treated With Tolvaptan For Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    The purpose of this study is to assess liver safety, non-liver safety, and effectiveness in subjects who previously experienced liver chemistry test ...